The significantly increased expression of several splicing factor genes, such as SF3B1, SRSF11 and SRSF7 (Figure 6H), in the high-risk group suggested that abnormal splicing was associated with an increased risk for PCa, such as progression. This evidence concerns the gene SF3B1 and posterior cortical atrophy.